retatrutide triple agonist gip glp-1 glucagon phase 2 obesity A review of an investigational drug retatrutide, a novel agent for the treatment of | European Journal of Clinical Pharmacology Retatrutide is a triple-agonist drug

Profiling of polyphenolics, nutrients and antioxidant potential of germplasms leaves from seven cultivars of Moringa oleifera lam

Cell Physiol Biochem 53:496507 Bissinger R, Bouguerra G, Al Mamun Bhuyan A, Waibel S, Abbs S, Lang F (2015) Efavirenz induced suicidal death of human erythrocytes

Prospective evaluation of laparoscopic pancreatic biopsies in 11 healthy cats

Al A, Hridoy M, Munny FJ, Shahriar F, Rahman M, Islam F, Kazmi A, Kawsar A (2025) Review article exploring the potentials of Sajana ( Moringa oleifera Lam.) as a plant-based feed ingredient to sustainable and good aquaculture practices: an analysis of growth performance and health benefits

Yoshida M, Takada T, Kawarada Y, Tanaka A, Nimura Y, Gomi H, Hirota M, Miura F, Wada K, Mayumi T, Solomkin JS, Strasberg S, Pitt HA, Belghiti J, de Santibanes E, Fan ST, Chen MF, Belli G, Hilvano SC, Kim SW, Ker CG (2007) Antimicrobial therapy for acute cholecystitis: Tokyo Guidelines

Preclinical studies have examined AOD-9604 in the context of articular cartilage repair, with laboratory models investigating its effects on chondrocyte activity and extracellular matrix synthesis